Method for elevating the concentration of free insulin-like growth factor
CA 2276049 A1 · Owner: Hashimoto, Ryuji · Inventors: Higashihashi, Nobuyuki; Hashimoto, Ryuji; Sakano, Katsuichi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for elevating the concentration of a free insulin-like growth factor (IGF) by converting IGF contained in living bodies into free IGF having a sufficient IGF activity; a method for elevating the concentration of the IGF/IGFP (insulin-like growth factor-binding protein) complex in living bodies; a substance enabling the elevation of the above concentrations; drugs containing this substance; and a method for screening this substance. Thus the IGF effect is expressed by administering not IGF externally but the substance capable of increasing free IGF in living bodies. This substance is useful as a preventive and/or remedy for diseases which can be prevented and/or treated by …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 26, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 26, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 26, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.